Pharmaceutical Commerce - July/August 2010

Vaccine working group tries to build consensus on temperature control and dispensing practices

An inaugural meeting was held in November; meanwhile Chinese government activities to shut down counterfeiting expand

CRM-software training company expands its international presence

Newly commercialized vaccine-production methods could moderate the feast-or-famine uncertainties of vaccine supply

Lawsuit claims a violation of Sherman Antitrust Act

Geared for time- and temperature-sensitive shipments like healthcare products, Proactive Response Secure insures delivery throughout the US

Integrated-network approach will offer lower costs compared to courier services--but what about reliability?

Intended to get patients on therapy quickly--and keep them there--the MedVantx sample closet addresses the problem of unfilled prescriptions for the newly diagnosed

Arrangement expands Cryoport's service agreement with the lab

CVS Caremark updates its list of blocked drugs that will not be available on its formularies, in part to battle manufacturers’ copay programs

InTouch Solutions, MD Mindset collaborate to tailor iPad content development

Analysis of 'pharmacy related waste' finds $408 billion in potential annual savings

Continuing growth attracts more players; meanwhile, Sensitech acquires FreightWatch International to beef up real-time monitoring

Private-equity firm builds a competitor in pharma sales analytics

Compiling and maintaining lists of healthcare provider contacts is a bigger and more important task than ever

US patients believe they are healthier than they actually are, and at the same time have a greater willingness to try new therapies

Press reports of the acquisition of Dik Drug Co. remain uncorroborated by Cardinal

Physician's Sunshine Act rules will not go into effect until 2013, with public reporting possible in 2014

Pharmaceutical Commerce’s updated Biopharma Sourcebook estimates a 2009 market of $5.9 billion, heading to $6.9 billion in 2012

US growth remains off the global pace, market will expand by 3-5%, to $320-330 billion

Annual polling and analysis for the Dow Jones Sustainability Index lists 20 healthcare companies

Distributing products within the European market calls for focused knowledge of national practices

More pieces for industry-wide track-and-trace are falling into place, but there’s no rush to authenticate products

New device links healthcare providers to patients for reminder notifications

As hundreds of candidate drugs receive official “orphan” status, the Orphan Drug Act gets re-examined. Meanwhile, these drugs are driving the growth of specialty pharmacy

The seemingly routine process of identifying and locating prescribing physicians is becoming a critical industry function

How Contract Manufacturers Can Help Pharma Through The Era of Divestiture

Record numbers of attendees and exhibitors came together at Philadelphia meeting